Cryogel scaffolds: soft and easy to use tools for neural tissue culture
Ben Newland, Katherine R Long
Neural Regeneration Research · 2022
doi:10.4103/1673-5374.335156 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The mammalian central nervous system (CNS) is highly complex, with a vast array of processes and interactions occurring in a dynamic and often transient manner. How these processes are combined to regulate our behavior remains poorly understood. This has in turn led to a lack of understanding of how these processes have gone awry in the many disorders of the nervous system. In order to address this, researchers need a controlled way to manipulate the nervous system in in vitro and ex vivo cultures, in both a specific area and for a specific period of time to start to pick apart these interactions. To date, this has been technically challenging, especially when modeling focal injury to the CNS or when working with human brain tissue. Here, we suggest that biomaterials could help bridge this gap. One technical challenge of manipulating nervous system tissue is that it is inherently soft and susceptible to mechanical damage. The use of biomaterials such as conventional hydrogels, which match the mechanical properties of the CNS, could help overcome this issue, but these have so far been hindered by their mechanical weakness. For instance, even microscale hydrogels with a Young's modulus as high as 30 kPa, over three times stiffer than brain tissue (Eigel et al., 2021a), could not be mechanically removed from their template without breaking (Eigel et al., 2021b), suggesting that they may be difficult to handle, load and place onto the CNS tissue itself. However, a more recently developed class of biomaterial, cryogelated hydrogels – or cryogels, offer a convenient solution to this problem. They can be extremely soft, whilst remaining mechanically tough enough to be handled with forceps. These mechanical properties make them particularly well-suited for the local delivery of reagents to brain and spinal cord tissue. These properties are also a major reason why cryogels have already been used for a wide range of biological applications (Razavi et al., 2019). Herein we discuss the recent development of cryogel tools for CNS manipulation and give our perspective on the future directions of this technology. Cryogels are similar to their hydrogel counterparts in that they are composed of a 3-dimensional hydrophilic network. However, an important difference is their macroporous structure, with comparatively large open pores surrounded by thin struts of hydrogel (Figures 1A and 2). This structure is obtained by freezing the hydrogel precursor solution prior to (or during) crosslinking, forcing the polymer network to form around the ice crystals (Eigel et al., 2021a). The sponge-like morphology of cryogels makes them tough, due to the condensed polymer network found in the struts. However, macroscopically they are soft and can be substantially compressed (Figure 1B), reforming to their original size and shape once the compressive force is removed (Bencherif et al., 2012). This is an important characteristic that enables these cryogels to be inserted and then later removed from CNS tissue (Eigel et al., 2021b).Figure 1: An overview of the properties of cryogels that make them useful biomaterials for neuroscience applications.(A) Scanning electron micrograph showing the cryogel struts and large macropores (scale bar: 50 µm). Adapted with permission from Newland et al. (2020). (B) Mechanical testing analysis comparing hydrogels and cryogels with exactly the same monomer composition, showing that cryogels can withstand greater stress and strain before rupture, despite being about three times macroscopically softer than the equivalent hydrogels. Adapted with permission from Eigel et al. (2021). (C) General overview of physical characteristics that are typical of hydrogels and cryogels. PEGDA-SPA: Poly(ethylene glycol) diacrylate-co-3-sulfopropyl acrylate.Figure 2: A representation of different cryogel structures used for neuroscience applications in culture, with scanning electron microscope images of example cryogel forms, current uses, and potential future uses.(A) Macroscale cylindrical cryogels have been used for modelling multiple sclerosis and hold potential for local drug delivery. (B) Elongated line-shaped cryogels have been used to deliver reagents to human fetal brain tissue, which could potentially be adapted to include genetic manipulation. (C) Hollow tube-shaped cryogels have been used as nerve guidance conduits which hold promise for both peripheral and central nervous system regeneration. (D) Microscale spherical cryogels (microcarriers) have recently been used as a 3D cell culture platform which could potentially be used for a wide range of in vivo applications. Reproduced with permission from Eigel et al. (2019) and Wu et al. (2019). CNS: Central nervous system; NGC: nerve guidance conduit.This mechanical toughness has enabled these macroscale cryogels to be easily used to deliver reagents to regional areas of tissue in culture and improve models of CNS injury. For example, cylinder-shaped cryogels were used to create a focal ex vivo model of demyelination (Eigel et al., 2019). These cryogels were dipped in a demyelinating agent, lysophosphatidylcholine, and then placed next to brain or spinal cord tissue slices in culture. As depicted in Figure 2A, this created a small region of demyelination surrounded by healthy tissue (Eigel et al., 2019). Aside from their ease of use, the cryogels also provided the important advantage of more accurately reproducing the patchy demyelination pathology observed in multiple sclerosis in humans (Eigel et al., 2019), in comparison to pre-existing “global demyelination” models (Zhang et al., 2011). This patchy demyelination allowed the role of the infiltrating glial cells, from the surrounding unaffected areas, in remyelination to be analyzed. Another advantage of this focal demyelination approach is that it can also be applied to create focal regions of demyelinated grey matter in vivo (Zoupi et al., 2021). This has allowed researchers to unpick mechanisms of demyelination vs. inflammation in neural degeneration, and highlight the selective vulnerability of specific neuronal types to degeneration following demyelination (Zoupi et al., 2021). The ability of the cryogels to improve the replication of patient pathology in these models highlights their potential to be further developed as a platform for analyzing therapeutics for remyelination. The mechanical toughness of cryogels has also proved useful when working with human brain tissue cultures. Cryogels generated using 3D printed templates have allowed researchers to label specific regions of human fetal brain tissue slices with fluorescent dyes, enabling specific cells to be identified and followed in culture (Eigel et al., 2021b). They have also been used to transiently apply a neurotoxin to reversibly and repeatedly inhibit neuron activity in a spatiotemporal manner within a brain tissue slice (Eigel et al., 2021b). Human tissue cultures lack many of the genetic tools available in animal models, but we speculate that cryogels could also be used to deliver genetic material to this tissue, either through viral vectors or non-viral constructs. A notable advantage of the cryogels for such applications is that as they are typically formed within a template, meaning that they can be created to almost any size or shape whilst retaining their properties post-compression (Bencherif et al., 2012). This has allowed the formation of high aspect ratio (elongated) line-shaped cryogels, which, despite narrow widths down to 150 µm, are strong enough to be handled with forceps, loaded with reagents and placed onto brain tissue slices (Figure 2B) (Eigel et al., 2021b; Ucar et al., 2021). This would enable cryogels to be made to order and reproducibly target a specified area of the brain tissue slice. This characteristic, alongside their ability to be removed without damaging the tissue (Eigel et al., 2021b), gives them a major advantage over conventional hydrogels, as those formed from the equivalent monomers/solid content cannot be handled without breaking (Eigel et al., 2021b; Figure 1C). Overall, cryogels have shown promise for use as biocompatible tools to deliver a wide range of cargos to neural tissue cultures, which could include CRISPR/cas9 systems, therapeutics and even cells. One characteristic of cryogels that makes them suitable tools for cell delivery is that the pore size of the scaffold can easily be adjusted by varying the freezing regime used (Eigel et al., 2021a). Slower freezing rates yield larger pores at sizes suitable for cell adherence and growth within the cryogel scaffold itself (Figure 2D) (Newland et al., 2020). Indeed, pores can be made sufficiently large enough to allow infiltration of the neural progenitor cells throughout the cryogel structure within the first three days of culture (Newland et al., 2020). When used as a 3D cell culture system, these cryogels allowed 28 days of neural progenitor cell culture without the formation of a necrotic core or spontaneous differentiation, two commonly occurring problems of 3D neurosphere cultures. In principle, this culture technique could be adapted to organoid cultures, potentially allowing organoids to retain a viable core as they grow. Whilst many of the aforementioned techniques have largely revolved around forming models of disease and manipulating cultures, cryogels have also been investigated for experimental therapeutic uses. An early study by Béduer and colleagues clearly highlighted the potential that cryogel scaffolds have for improving cell transplantation (Béduer et al., 2015). Large neuronal networks could be grown on the cryogels, which, to prove injection feasibility, were compressed through a needle without damage or loss of viability (Béduer et al., 2015). Continuation of this work led to the formation of neurothreads, elongated cryogel cylinders within which dopaminergic neuron progenitor cells can be cultured and matured. Transplantation of neurothre
Abstract licence: CC BY-NC-SA
References14
14 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.